









市場行情
/
股票
/
nasdaq-dva
/

DaVita Inc

DVA

111.450USD

-1.140-1.01%

收盤 01/09, 16:00（美東）報價延遲15分鐘

7.91B總市值

11.23本益比TTM



DaVita Inc

111.450

-1.140-1.01%

概覽公司財務分析

概覽

公司

財務

分析

關於 DaVita Inc 公司

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

DaVita Inc簡介



公司代碼DVA

公司名稱DaVita Inc

上市日期Oct 31, 1995

CEORodriguez (Javier J)

員工數量76000

證券類型Ordinary Share

年結日Oct 31

公司地址2000 16th St

城市DENVER

上市交易所NASDAQ OMX NASDAQ Basic NYSE

國家United States of America

郵編80202-5117

電話13105362668

網址https://www.davita.com/

公司代碼DVA

上市日期Oct 31, 1995

CEORodriguez (Javier J)

DaVita Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Javier J. Rodriguez

Chief Executive Officer, Director

832.67K

-5165.00%

Mr. Joel Ackerman

Chief Financial Officer, Treasurer

101.00K

+8191.00%

Ms. Kathleen Alyce Waters

Chief Legal and Public Affairs Officer

66.98K

+7388.00%

Ms. Pamela M. Arway

Independent Chair of the Board

26.36K

+411.00%

Mr. Christopher Michael (Chris) Berry

Chief Accounting Officer

15.96K

+3834.00%

Mr. James O. Hearty

Chief Compliance Officer

14.54K

+260.00%

Ms. Phyllis R. Yale

Independent Director

13.98K

+411.00%

Ms. Barbara J. Desoer

Independent Director

13.44K

+411.00%

Mr. David P. Maughan

Chief Operating Officer - Davita Kidney Care

13.08K

-7501.00%

Dr. Gregory J. Moore, M.D., Ph.D.

Independent Director

7.23K

+411.00%

名稱

名稱/職務

職務

持股

持股變動

Mr. Javier J. Rodriguez

Chief Executive Officer, Director

832.67K

-5165.00%

Mr. Joel Ackerman

Chief Financial Officer, Treasurer

101.00K

+8191.00%

Ms. Kathleen Alyce Waters

Chief Legal and Public Affairs Officer

66.98K

+7388.00%

Ms. Pamela M. Arway

Independent Chair of the Board

26.36K

+411.00%

Mr. Christopher Michael (Chris) Berry

Chief Accounting Officer

15.96K

+3834.00%

Mr. James O. Hearty

Chief Compliance Officer

14.54K

+260.00%

收入明細

單位: USD更新時間: 1月6日週二

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

Patient service - Medicare and Medicare Advantage

1.72B

50.15%

Patient service - Commercial

1.06B

30.86%

Patient service - Other government

324.62M

9.49%

Patient service - Medicaid and Managed Medicaid

214.66M

6.28%

Other - Medicare and Medicare Advantage

85.88M

2.51%

其他

24.33M

0.71%

由於公司未披露，未能獲取相關數據

業務

地區

業務USD

名稱

營收

佔比

Patient service - Medicare and Medicare Advantage

1.72B

50.15%

Patient service - Commercial

1.06B

30.86%

Patient service - Other government

324.62M

9.49%

Patient service - Medicaid and Managed Medicaid

214.66M

6.28%

Other - Medicare and Medicare Advantage

85.88M

2.51%

其他

24.33M

0.71%

股東統計

更新時間: 12月4日週四

持股股東

股東類型

持股股東

佔比

Berkshire Hathaway Inc.

44.98%

The Vanguard Group, Inc.

5.96%

BlackRock Institutional Trust Company, N.A.

3.39%

Weschler (R Ted)

3.09%

State Street Investment Management (US)

2.60%

其他

39.97%

持股股東

佔比

Berkshire Hathaway Inc.

44.98%

The Vanguard Group, Inc.

5.96%

BlackRock Institutional Trust Company, N.A.

3.39%

Weschler (R Ted)

3.09%

State Street Investment Management (US)

2.60%

其他

39.97%

股東類型

持股股東

佔比

Holding Company

44.99%

Investment Advisor

25.80%

Investment Advisor/Hedge Fund

14.44%

Hedge Fund

5.47%

Individual Investor

5.06%

Research Firm

2.42%

Pension Fund

2.16%

Bank and Trust

0.87%

Sovereign Wealth Fund

0.35%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

1272

36.41M

51.56%

-4.55M

2025Q3

1299

36.28M

57.59%

-1.47M

2025Q2

1288

37.75M

54.27%

+725.11K

2025Q1

1275

37.24M

54.43%

-4.83M

2024Q4

1234

39.31M

53.45%

-1.10M

2024Q3

1192

40.91M

54.63%

-1.68M

2024Q2

1162

42.62M

55.55%

-1.85M

2024Q1

1146

44.41M

55.70%

-4.44M

2023Q4

1143

45.66M

55.03%

+259.36K

2023Q3

1139

46.32M

54.25%

+1.22M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Berkshire Hathaway Inc.

31.76M

44.98%

-401.51K

-1.25%

Oct 27, 2025

The Vanguard Group, Inc.

4.21M

5.96%

-518.53K

-10.97%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

2.40M

3.39%

-242.29K

-9.18%

Sep 30, 2025

Weschler (R Ted)

2.18M

3.09%

Aug 06, 2024

State Street Investment Management (US)

1.83M

2.6%

-258.50K

-12.35%

Sep 30, 2025

Invesco Capital Management LLC

1.40M

1.98%

+57.02K

+4.25%

Sep 30, 2025

Gates Capital Management, Inc.

1.19M

1.69%

+91.40K

+8.32%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

1.09M

1.54%

+88.06K

+8.83%

Sep 30, 2025

Geode Capital Management, L.L.C.

1.02M

1.45%

-86.31K

-7.78%

Sep 30, 2025

LSV Asset Management

927.03K

1.31%

-13.70K

-1.46%

Sep 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

Aztlan Global Stock Selection DM SMID ETF

2.59%

State Street SPDR S&P Health Care Services ETF

1.84%

Strategas Global Policy Opportunities ETF

1.64%

Invesco S&P 500 Equal Weight Health Care ETF

1.47%

Pacer US Cash Cows Growth ETF

1.02%

AdvisorShares Insider Advantage ETF

0.95%

Global X Aging Population ETF

0.75%

iShares U.S. Healthcare Providers ETF

0.67%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

0.67%

LeaderShares AlphaFactor US Core ETF

0.66%

Aztlan Global Stock Selection DM SMID ETF

佔比2.59%

State Street SPDR S&P Health Care Services ETF

佔比1.84%

Strategas Global Policy Opportunities ETF

佔比1.64%

Invesco S&P 500 Equal Weight Health Care ETF

佔比1.47%

Pacer US Cash Cows Growth ETF

佔比1.02%

AdvisorShares Insider Advantage ETF

佔比0.95%

Global X Aging Population ETF

佔比0.75%

iShares U.S. Healthcare Providers ETF

佔比0.67%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

佔比0.67%

LeaderShares AlphaFactor US Core ETF

佔比0.66%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

DaVita Inc的前五大股東是誰？



DaVita Inc的前五大股東如下：
Berkshire Hathaway Inc.
持有股份：31.76M
佔總股份比例：44.98%。
The Vanguard Group, Inc.
持有股份：4.21M
佔總股份比例：5.96%。
BlackRock Institutional Trust Company, N.A.
持有股份：2.40M
佔總股份比例：3.39%。
Weschler (R Ted)
持有股份：2.18M
佔總股份比例：3.09%。
State Street Investment Management (US)
持有股份：1.83M
佔總股份比例：2.60%。